• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

人T细胞的转化生长因子-β(TGF-β)信号传导受辅助性TGF-β受体内皮糖蛋白调节。

TGF-{beta} signaling of human T cells is modulated by the ancillary TGF-{beta} receptor endoglin.

作者信息

Schmidt-Weber Carsten B, Letarte Michelle, Kunzmann Steffen, Rückert Beate, Bernabéu Carmelo, Blaser Kurt

机构信息

Swiss Institute of Allergy and Asthma Research, Obere Strasse 22, CH-7270 Davos, Switzerland.

出版信息

Int Immunol. 2005 Jul;17(7):921-30. doi: 10.1093/intimm/dxh272. Epub 2005 Jun 20.

DOI:10.1093/intimm/dxh272
PMID:15967783
Abstract

Transforming growth factor beta (TGF-beta) inhibits T cell activation and alters differentiation of naive T cells into effector cells. Although four main cell-surface proteins can interact with TGF-beta, only the signaling receptors type I (TGF-betaR type I) and type II (TGF-betaR type II) have so far been described on T cells. The aim of the present study was to investigate the expression of the ancillary receptor endoglin (CD105) by T cells and its role in TGF-beta-mediated signal transduction and function. CD105 expression was analyzed on resting and activated human CD4(+) T cells by flow cytometry, western blot, immunoprecipitation, proliferation and SMAD-responsive reporter gene assays. CD4(+) T cells constitutively expressed CD105 in memory T cells and partially also in naive T cells; however, surface expression is regulated and is increased following TCR engagement, which induced serine/threonine phosphorylation of CD105. In contrast to the suppressive signal mediated by the TGF-beta, cross-linking of CD105 substantially enhanced T cell proliferation, indicating that CD105 by itself mediates signal transduction. Furthermore, CD105 cross-linking induced SMAD-independent signaling via ERK kinase phosphorylation. The present study demonstrates that CD105 is expressed on the surface by activated CD4(+) T cells and CD3 regulated by post-translational means. Furthermore, CD105 acts as a regulatory receptor, counteracting TGF-beta-mediated suppression.

摘要

转化生长因子β(TGF-β)可抑制T细胞活化,并改变初始T细胞向效应细胞的分化。尽管有四种主要的细胞表面蛋白可与TGF-β相互作用,但迄今为止,在T细胞上仅发现了I型信号受体(TGF-βR I型)和II型信号受体(TGF-βR II型)。本研究的目的是探究T细胞辅助受体内皮糖蛋白(CD105)的表达及其在TGF-β介导的信号转导和功能中的作用。通过流式细胞术、蛋白质免疫印迹法、免疫沉淀法、增殖实验以及SMAD反应性报告基因检测,对静息和活化的人CD4⁺ T细胞上的CD105表达进行了分析。CD4⁺ T细胞在记忆T细胞中组成性表达CD105,在部分初始T细胞中也有表达;然而,其表面表达受到调控,在TCR激活后会增加,这会诱导CD105的丝氨酸/苏氨酸磷酸化。与TGF-β介导的抑制信号相反,CD105的交联显著增强了T细胞增殖,表明CD105自身可介导信号转导。此外,CD105交联通过ERK激酶磷酸化诱导非SMAD信号通路。本研究表明,活化的CD4⁺ T细胞表面通过翻译后修饰方式表达CD105和CD3。此外,CD105作为一种调节性受体,可抵消TGF-β介导的抑制作用。

相似文献

1
TGF-{beta} signaling of human T cells is modulated by the ancillary TGF-{beta} receptor endoglin.人T细胞的转化生长因子-β(TGF-β)信号传导受辅助性TGF-β受体内皮糖蛋白调节。
Int Immunol. 2005 Jul;17(7):921-30. doi: 10.1093/intimm/dxh272. Epub 2005 Jun 20.
2
Endoglin is a component of the transforming growth factor (TGF)-beta receptor complex of human pre-B leukemic cells.内皮糖蛋白是人类前B淋巴细胞白血病细胞转化生长因子(TGF)-β受体复合物的一个组成部分。
J Immunol. 1996 Jan 15;156(2):564-73.
3
TNF alpha down-regulates CD105 expression in vascular endothelial cells: a comparative study with TGF beta 1.肿瘤坏死因子α下调血管内皮细胞中CD105的表达:与转化生长因子β1的对比研究。
Anticancer Res. 2003 Mar-Apr;23(2B):1189-96.
4
CD105 (endoglin) expression on hematopoietic stem/progenitor cells.造血干/祖细胞上CD105(内皮糖蛋白)的表达。
Leuk Lymphoma. 2001 Nov-Dec;42(6):1195-206. doi: 10.3109/10428190109097744.
5
Extracellular and cytoplasmic domains of endoglin interact with the transforming growth factor-beta receptors I and II.内皮糖蛋白的细胞外结构域和细胞质结构域与转化生长因子-β受体I和II相互作用。
J Biol Chem. 2002 Aug 9;277(32):29197-209. doi: 10.1074/jbc.M111991200. Epub 2002 May 15.
6
Interaction and functional interplay between endoglin and ALK-1, two components of the endothelial transforming growth factor-beta receptor complex.内皮细胞转化生长因子-β受体复合物的两个组成部分,内皮糖蛋白和ALK-1之间的相互作用及功能协同。
J Cell Physiol. 2005 Aug;204(2):574-84. doi: 10.1002/jcp.20311.
7
Endoglin promotes endothelial cell proliferation and TGF-beta/ALK1 signal transduction.内皮糖蛋白促进内皮细胞增殖及转化生长因子-β/激活素受体样激酶1信号转导。
EMBO J. 2004 Oct 13;23(20):4018-28. doi: 10.1038/sj.emboj.7600386. Epub 2004 Sep 23.
8
Transforming growth factor-beta inhibits human antigen-specific CD4+ T cell proliferation without modulating the cytokine response.转化生长因子-β抑制人类抗原特异性CD4+ T细胞增殖,而不调节细胞因子反应。
Int Immunol. 2003 Dec;15(12):1495-504. doi: 10.1093/intimm/dxg147.
9
Endoglin is an accessory protein that interacts with the signaling receptor complex of multiple members of the transforming growth factor-beta superfamily.内皮糖蛋白是一种辅助蛋白,可与转化生长因子-β超家族多个成员的信号受体复合物相互作用。
J Biol Chem. 1999 Jan 8;274(2):584-94. doi: 10.1074/jbc.274.2.584.
10
Acquisition of anergic and suppressive activities in transforming growth factor-beta-costimulated CD4+CD25- T cells.在转化生长因子-β共刺激的CD4+CD25-T细胞中获得无反应性和抑制活性。
Int Immunol. 2004 Aug;16(8):1203-13. doi: 10.1093/intimm/dxh123. Epub 2004 Jul 5.

引用本文的文献

1
A systematic review and meta-analysis of the endothelial-immune candidate biomarker endoglin in rheumatic diseases.系统性综述和荟萃分析:风湿性疾病中内皮-免疫候选生物标志物内脂素。
Clin Exp Med. 2024 Nov 13;25(1):4. doi: 10.1007/s10238-024-01519-5.
2
Small extracellular vesicles are released ex vivo from platelets into serum and from residual blood cells into stored plasma.小细胞外囊泡在体外从血小板释放到血清中,并从残留血细胞释放到储存的血浆中。
J Extracell Biol. 2023 May 12;2(5):e88. doi: 10.1002/jex2.88. eCollection 2023 May.
3
Identification of CD105 (endoglin) as novel risk marker in CLL.
鉴定 CD105(内皮糖蛋白)作为 CLL 的新型风险标志物。
Ann Hematol. 2022 Apr;101(4):773-780. doi: 10.1007/s00277-022-04756-4. Epub 2022 Jan 19.
4
Endoglin in the Spotlight to Treat Cancer.内皮糖蛋白成为癌症治疗新焦点。
Int J Mol Sci. 2021 Mar 20;22(6):3186. doi: 10.3390/ijms22063186.
5
Hot and Cold Tumors: Is Endoglin (CD105) a Potential Target for Vessel Normalization?热肿瘤与冷肿瘤:内皮糖蛋白(CD105)是血管正常化的潜在靶点吗?
Cancers (Basel). 2021 Mar 28;13(7):1552. doi: 10.3390/cancers13071552.
6
Endoglin: An 'Accessory' Receptor Regulating Blood Cell Development and Inflammation.内皮糖蛋白:调节血细胞发育和炎症的“辅助”受体。
Int J Mol Sci. 2020 Dec 3;21(23):9247. doi: 10.3390/ijms21239247.
7
Reduction of endoglin receptor impairs mononuclear cell-migration.内皮糖蛋白受体的减少会损害单核细胞迁移。
Explor Med. 2020;1:136-148. doi: 10.37349/emed.2020.00010. Epub 2020 Jun 29.
8
Impaired Release of Neutrophil Extracellular Traps and Anemia-Associated T Cell Deficiency in Hereditary Hemorrhagic Telangiectasia.遗传性出血性毛细血管扩张症中中性粒细胞胞外陷阱释放受损与贫血相关的T细胞缺陷
J Clin Med. 2020 Mar 12;9(3):767. doi: 10.3390/jcm9030767.
9
Endoglin: Beyond the Endothelium.内皮糖蛋白:超越内皮。
Biomolecules. 2020 Feb 12;10(2):289. doi: 10.3390/biom10020289.
10
A Phase II Clinical Trial of TRC105 (Anti-Endoglin Antibody) in Adults With Advanced/Metastatic Urothelial Carcinoma.TRC105(抗内皮糖蛋白抗体)用于晚期/转移性尿路上皮癌成人患者的II期临床试验。
Clin Genitourin Cancer. 2017 Feb;15(1):77-85. doi: 10.1016/j.clgc.2016.05.010. Epub 2016 May 27.